ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

Novartis's Sandoz gets FDA approval for biosimilar multiple sclerosis drug
Novartis's Sandoz gets FDA approval for biosimilar multiple sclerosis drug
Announcement as on 25 August 2023

Novartis says planned spinoff of Sandoz unit will take place around Oct. 4
Novartis says planned spinoff of Sandoz unit will take place around Oct. 4
Announcement as on 18 August 2023

European shares gain on boost from Novartis, telecom stocks drag
Europe's healthcare sector, up 0.4%, also got a boost from 3.9% gains in shares of Swedish Orphan Biovitrum (SOBI) after the drugmaker's second-quarter earnings beat estimates.
Announcement as on 18 July 2023

: Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a .5 billion deal
Bausch + Lomb Corp. BLCO confirmed that it was buying the “dry eye” treatment Xiidra from Novartis AG NVSCH:NOVN in a deal valued at .5 billion. Under terms of the deal, Bausch + Lomb will make an upfront payment of .75 billion in cash, and could m
Announcement as on 30 June 2023

: Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a .5 billion deal
Bausch + Lomb Corp. BLCO confirmed that it was buying the “dry eye” treatment Xiidra from Novartis AG NVSCH:NOVN in a deal valued at .5 billion. Under terms of the deal, Bausch + Lomb will make an upfront payment of .75 billion in cash, and could m
Announcement as on 30 June 2023

Announcements by Novartis first page | Next page | Prev page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 1947.66
  • 12Day Average: 1963.78
  • 20Day Average: 1993.34
  • 50Day Average: 1789.1
  • 100Day Average: 1630.29
  • 150Day Average: 1424.81
  • 200Day Average: 1273.02

500672 Indicators & signals

Indicator MACD (12,26,9)

1960.71, 1926.05, 60.32
Indicator MACD is in positive zone

Indicator ADX (14)

14.45, 26.37, 19.71
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 63
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Mon Oct 2026 1922.90 1869.35 to 1939.95 1.17% 0.27 times
16 Fri Oct 2026 1900.65 1850.00 to 1941.00 -1.89% 0.41 times
15 Thu Oct 2026 1937.30 1925.00 to 1970.45 -2.59% 0.25 times
14 Wed Oct 2026 1988.85 1963.00 to 2005.95 0.01% 0.37 times
13 Tue Oct 2026 1988.60 1939.95 to 2037.95 -1.23% 0.57 times
12 Mon Oct 2026 2013.35 2001.00 to 2101.85 -1.74% 0.31 times
06 Tue Oct 2026 2049.05 1942.15 to 2072.75 4.19% 1.19 times
05 Mon Oct 2026 1966.70 1961.65 to 2164.60 -0.06% 4.21 times
01 Thu Oct 2026 1967.85 1900.00 to 1979.95 1.78% 1.06 times
29 Tue Sep 2026 1933.35 1903.75 to 1977.90 -0.1% 0.67 times
28 Mon Sep 2026 1935.30 1925.70 to 2026.75 -1.33% 0.97 times
25 Fri Sep 2026 1961.40 1939.00 to 1979.95 -0.46% 0.48 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top